Rating: Strong Buy
Amgen Financial Health
Profitability:8.88/10
✅ Amgen has better Profitability than 71.43% of the companies on the Biotechnology industry
Net Margin: 29.98%
✅ Amgen has better Net Margin than 70% of the companies on the Biotechnology industry
ROE (Return on Equity): 8.78%
✅ Amgen has better ROE (Return on Equity) than 66.67% of the companies on the Biotechnology industry
ROA (Return on Assets): 2.93%
✅ Amgen has better ROA (Return on Assets) than 70% of the companies on the Biotechnology industry
Operating Efficiency:9.42/10
✅ Amgen has better Operating Efficiency than 75% of the companies on the Biotechnology industry
Operating Margin: 37.42%
✅ Amgen has better Operating Margin than 75% of the companies on the Biotechnology industry
Liquidity:7.75/10
❌ Amgen has worst Liquidity than 71.43% of the companies on the Biotechnology industry
Quick Ratio: 1.88
❌ Amgen has worst Quick Ratio than 90.48% of the companies on the Biotechnology industry
Operating Cash Flow Ratio: 1.18
✅ Amgen has better Operating Cash Flow Ratio than 70% of the companies on the Biotechnology industry
Solvency:1.12/10
❌ Amgen has worst Solvency than 100% of the companies on the Biotechnology industry
Debt to Equity Ratio: 3.13
❌ Amgen has worst Debt to Equity Ratio than 95% of the companies on the Biotechnology industry
Interest Coverage Ratio: 1.18
✅ Amgen has better Interest Coverage Ratio than 70% of the companies on the Biotechnology industry